Earnings Feed
Start Free
Home/Filings/4/0001144204-14-004038
4//SEC Filing

Chelsea Therapeutics International, Ltd. 4

Accession 0001144204-14-004038

CIK 0001333763operating
View on SEC.govCompany Profile

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 8:06 PM ET

Size

20.6 KB

Accession

0001144204-14-004038

Insider Transaction Report

Form 4
Period: 2014-01-22
Chelsea Therapeutics International, Ltd.CHTP
Clemens Kevan
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2014-01-22+35,000→ 35,000 total
    Exercise: $4.65Exp: 2024-01-22→ Common Stock (35,000 underlying)
Holdings

  • Stock Option (Right to Buy)

    Exercise: $0.96Exp: 2023-01-07→ Common Stock (35,000 underlying)
    35,000

  • Stock Option (Right to Buy)

    Exercise: $4.54Exp: 2022-01-25→ Common Stock (40,000 underlying)
    40,000

  • Stock Option (Right to Buy)

    Exercise: $1.78Exp: 2019-01-22→ Common Stock (40,000 underlying)
    40,000

  • Stock Option (Right to Buy)

    Exercise: $6.50Exp: 2018-01-24→ Common Stock (42,500 underlying)
    42,500

  • Stock Option (Right to Buy)

    Exercise: $7.72Exp: 2021-01-11→ Common Stock (40,000 underlying)
    40,000

  • Stock Option (Right to Buy)

    Exercise: $5.68Exp: 2017-02-06→ Common Stock (42,500 underlying)
    42,500

  • Stock Option (Right to Buy)

    Exercise: $0.20Exp: 2014-09-08→ Common Stock (35,210 underlying)
    35,210

  • Stock Option (Right to Buy)

    Exercise: $2.96Exp: 2020-01-19→ Common Stock (40,000 underlying)
    40,000

  • Common Stock

    5,000

  • Stock Option (Right to Buy)

    Exercise: $1.77Exp: 2014-12-31→ Common Stock (50,000 underlying)
    50,000

  • Stock Option (Right to Buy)

    Exercise: $1.15Exp: 2022-07-23→ Common Stock (35,000 underlying)
    35,000

  • Stock Option (Right to Buy)

    Exercise: $3.26Exp: 2016-01-19→ Common Stock (30,000 underlying)
    30,000
Footnotes (12)
  • [F1]Option vests in four equal annual installments beginning on January 22, 2015.
  • [F10]Option vested in four equal annual installments beginning on February 6, 2008.
  • [F11]Option vested in four equal annual installments beginning on January 19, 2007.
  • [F12]Option vested in four equal annual installments beginning on September 8, 2005.
  • [F2]Option vests upon a change in control of the Company.
  • [F3]Option vests in four equal annual installments beginning on January 7, 2014.
  • [F4]Option vests in four equal annual installments beginning on July 23, 2013.
  • [F5]Option vests in four equal annual installments beginning on January 25, 2013.
  • [F6]Option vests in four equal annual installments beginning on January 11, 2012.
  • [F7]Option vested in four equal annual installments beginning on January 19, 2011.
  • [F8]Option vested in four equal annual installments beginning on January 22, 2010.
  • [F9]Option vested in four equal annual installments beginning on January 24, 2009.

Documents

1 file

Issuer

Chelsea Therapeutics International, Ltd.

CIK 0001333763

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001333763

Filing Metadata

Form type
4
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 8:06 PM ET
Size
20.6 KB
View on SEC.gov